Works matching IS 09024441 AND DT 2020 AND VI 104 AND IP 4


Results: 11
    1
    2
    3
    4
    5
    6
    7

    Blinatumomab vs historic standard‐of‐care treatment for minimal residual disease in adults with B‐cell precursor acute lymphoblastic leukaemia.

    Published in:
    European Journal of Haematology, 2020, v. 104, n. 4, p. 299, doi. 10.1111/ejh.13375
    By:
    • Gökbuget, Nicola;
    • Dombret, Hervé;
    • Giebel, Sebastian;
    • Brüggemann, Monika;
    • Doubek, Michael;
    • Foa, Robin;
    • Hoelzer, Dieter;
    • Kim, Christopher;
    • Martinelli, Giovanni;
    • Parovichnikova, Elena;
    • Maria Ribera, Josep;
    • Schoonen, Marieke;
    • Tuglus, Catherine;
    • Zugmaier, Gerhard;
    • Bassan, Renato
    Publication type:
    Article
    8
    9

    High‐dose cyclophosphamide for hard‐to‐treat patients with relapsed or refractory B‐cell non‐Hodgkin's lymphoma, a phase II result.

    Published in:
    European Journal of Haematology, 2020, v. 104, n. 4, p. 281, doi. 10.1111/ejh.13369
    By:
    • Michot, Jean‐Marie;
    • Annereau, Maxime;
    • Danu, Alina;
    • Legoupil, Clémence;
    • Bertin, Louis;
    • Chahine, Claude;
    • Achab, Nadia;
    • Antosikova, Anna;
    • Cerutti, Ariane;
    • Rossignol, Julien;
    • Ghez, David;
    • Willekens, Christophe;
    • Dartigues, Peggy;
    • Lazarovici, Julien;
    • Lemare, Francois;
    • Ribrag, Vincent
    Publication type:
    Article
    10
    11

    Issue Information.

    Published in:
    European Journal of Haematology, 2020, v. 104, n. 4, p. 279, doi. 10.1111/ejh.13254
    Publication type:
    Article